Key result
Early target lumen enlargement was observed in 56.6% of lesions within 1 year after drug-coated balloon angioplasty, while 57.1% of lesions without early enlargement developed it later.
Why the study?
Target lumen enlargement is often observed after DCB angioplasty, but the long-term prognosis of coronary lesions with or without target lumen enlargement has not been clearly elucidated.
Cohort (n=193)
Answers are grounded in this paper and cite their sources.
Target lumen enlargement occurs frequently after drug-coated balloon angioplasty for de novo coronary lesions, presenting either early (within 1 year) or late (>1 year) without aneurysm formation.
BACKGROUND: Target lumen enlargement (TLE) or "late lumen enlargement" is often encountered after percutaneous coronary intervention (PCI) with drug-coated balloons (DCB). To date, the prognosis of coronary arterial lesions with or without TLE has not been clearly elucidated. AIMS: This study aimed to assess the long-term prognosis of coronary arterial lesions with or without TLE observed within 1 year (early TLE) after DCB angioplasty using serial quantitative angiographic follow-up. METHODS: One hundred and ninety-three consecutive patients (de novo coronary arterial lesions, 251) who underwent follow-up angiography within 1 year after DCB angioplasty (early follow-up, median: 6 months) were retrospectively evaluated. Of these, 97 patients (125 lesions) also underwent angiography more than 1 year after DCB angioplasty (late follow-up, median: 37 months). TLE was defined as an increase in minimal lumen diameter (MLD) after PCI at each follow-up. RESULTS: Early TLE was detected in 142 lesions (56.6%). Of these, 76 lesions were also evaluated at late follow-up. TLE persisted even at late follow-up in 67 of the 76 lesions (88.2%). An increase in MLD in early TLE (+) lesions was observed in the period between post-PCI and early follow-up (1.84 ± 0.06 vs. 2.12 ± 0.07 mm, p < 0.001) but not between early and late follow-up (2.12 ± 0.07 vs. 2.16 ± 0.07 mm, p = 0.74). In contrast, 49 of 109 lesions without early TLE were evaluated at late follow-up, of which 28 lesions (57.1%) showed TLE at late follow-up. The MLD of early TLE (-) lesions (n = 49) significantly increased from early (1.63 ± 0.061 mm) to late follow-up (1.84 ± 0.06 mm) (p < 0.001). No aneurysms were found in any of these cases. CONCLUSION: Early TLE was observed in more than half of the lesions, with the majority remaining at late follow-up. Alternatively, half of the lesions without early TLE showed late TLE, occurring biphasically after DCB angioplasty.
No takes yet. Share an insight, caveat, or question.
Ueno et al. (2023) conducted a cohort in Native coronary artery disease (n=193). Drug-coated balloon angioplasty was evaluated on Early target lumen enlargement (TLE) within 1 year. Early target lumen enlargement was observed in 56.6% of lesions within 1 year after drug-coated balloon angioplasty, while 57.1% of lesions without early enlargement developed it later.
Synapse has enriched 10 related papers. Consider them for comparative context: